The past fortnight’s Sens disclosures again illustrate a market divided between directors signalling conviction through personal buying and institutions repositioning portfolios across the bourse.
At Argent Industrial, CEO Treve Hendry trimmed his holding with back-to-back disposals worth more than R2.4m. Directors’ sales often set off alarms, but Argent’s share price has rallied 7% over the past six months, suggesting Hendry may simply be banking gains.
In contrast, at RCL Foods, CEO Paul Cruickshank made no fewer than six purchases in early September, scooping up more than 318,000 shares for just north of R3.1m. Such sustained accumulation by a single insider underscores confidence in the slimmed-down food manufacturer.
The market also saw buying conviction from Sabvest Capital’s CFO, Kyle De Matteis, who added nearly R8.4m worth of shares across four trades. That aligns with Sabvest’s reputation as a patient capital allocator, and suggests management sees value at current levels. Similarly, Spar CFO Reeza Isaacs and Nepi Rockcastle nonexecutive director André van der Veer both dipped into the market, though with smaller ticket sizes.
On the institutional side, shifts in ownership paint an equally intriguing picture. The Public Investment Corp (PIC) has been an active hand, paring back in Renergen and Resilient Reit while simultaneously raising its stake to 17.2% in newly demerged Valterra Platinum. That move coincides with Anglo American’s complete exit from Valterra, an offload that clears the way for long-term investors like the PIC and BlackRock, which also crossed the 5% threshold. The reshaping of Valterra’s register marks a critical moment as the platinum miner seeks to establish itself outside Anglo’s shadow.
On the institutional side, shifts in the consumer and industrial sectors stood out. Sanlam Investment Management trimmed its interest in Astral Foods to below 5%, reducing exposure just as the poultry group grapples with input-cost volatility. Absa Capital Securities’ clients lifted their stake in industrial conglomerate Barloworld to 8%, while Silchester International Investors pared back to 14.8%.
Clicks’ ongoing share buyback has reduced the overall shares in issue, passively lifting the Royal Bank of Canada’s percentage holding
Elsewhere fund managers are jostling across the consumer and health-care counters. Coronation’s clients edged up to nearly 12% in Aspen Pharmacare, while Allan Gray accumulated a fresh 5.5% interest in Dis-Chem. Lazard Asset Management emerged with a chunky 15.6% in Life Healthcare, a stake large enough to influence strategy in a sector undergoing consolidation.
At Clicks, the Royal Bank of Canada’s asset management arm crossed the 5% threshold, but this wasn’t the result of new buying. Instead, Clicks’s ongoing share buyback has reduced the overall shares in issue, passively lifting the bank’s percentage holding. Meanwhile, Hammerson disclosed that Coronation Fund Managers in Cape Town nudged its voting rights in the UK-listed property group above 9%.
The week also was not without notable disposals: MTN COO Jens Schulte-Bockum sold R14m worth of shares, sizeable even for a director of Africa’s largest telecoms group. While one sale doesn’t spell a trend, investors will watch closely for further insider movements.
And finally, KAP saw purchases by associates of both chair Johan Holtzhausen and CFO Frans Olivier, together worth nearly R700,000. Insider buying at this level isn’t transformative, but in a stock trading below 200c even modest purchases can signal management’s conviction in the group’s undervalued story.
A2X activity
Secondary listings on A2X continue to gain traction, with September so far averaging more than R1bn in daily trade.
Prosus alone accounted for nearly a third of turnover, with R936m changing hands (31.9% of total A2X activity). Investec followed at R196m (13.4%), just ahead of Richemont, which saw R192m worth of shares traded (11.6%).
Among local heavyweights, Absa contributed R150m (10.4%) and Sanlam R108m (9.6%).
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.